Orchard Therapeutics PLC
Maryam Jangani is a highly experienced scientist currently serving as Principal Scientist in Analytical Development at Orchard Therapeutics since September 2025. Previously, at Adaptimmune, Maryam Jangani contributed to the Process Development analytical group from February 2021 to October 2025, focusing on immunological assays development in compliance with ICH guidelines. Earlier roles include Principal Researcher at Eisai EMEA, Senior Scientist at Horizon Discovery, and Postdoctoral Research Fellow at Queen Mary University of London. With a PhD in Molecular Medicine from The University of Manchester, along with a Master's degree in Biological and Biomedical Sciences and a Bachelor's degree in Pharmacology, Maryam Jangani has a solid foundation in molecular biology and applications in immunology and oncology research.
This person is not in the org chart
This person is not in any teams
This person is not in any offices